// Deep Analysis

Research & Analysis.
In-Depth.

Full-length, AI-written pieces grounded in real filings and disclosures — factual filing digests and thesis-derived research analysis, distinct from the real-time wire feed.

12,825
Articles Published
Live
Feed Status
ALL ANALYSIS · 12,825 results Live
Filing Digest Sep 17

Aquestive Resubmits NDA for Anaphylm to FDA

Aquestive Therapeutics, Inc. announced on September 17, 2026, that it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Anaphylm (di…